Detalhe da pesquisa
1.
One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines.
J Infect Dis
; 227(10): 1203-1213, 2023 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36408618
2.
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
N Engl J Med
; 381(20): 1897-1908, 2019 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31722150
3.
Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses.
J Infect Dis
; 224(8): 1372-1382, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33675226
4.
Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine.
J Infect Dis
; 223(6): 1062-1072, 2021 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32726422
5.
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.
N Engl J Med
; 374(17): 1635-46, 2016 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25629663
6.
CD70 encoded by modified vaccinia virus Ankara enhances CD8 T-cell-dependent protective immunity in MHC class II-deficient mice.
Immunology
; 154(2): 285-297, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29281850
7.
A Modified Vaccine against Smallpox. Reply.
N Engl J Med
; 382(13): 1285-1286, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32212534
8.
Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
J Virol
; 91(11)2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28331098
9.
Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses.
J Virol
; 88(24): 14396-411, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25297997
10.
Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects.
J Infect Dis
; 207(5): 749-58, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23225902
11.
The vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulence.
J Virol
; 86(4): 2323-36, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22171261
12.
Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication.
Sci Rep
; 13(1): 5162, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997583
13.
A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection.
Front Immunol
; 13: 841471, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35774800
14.
A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques.
Front Immunol
; 13: 857440, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35479095
15.
Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection.
J Clin Invest
; 118(5): 1776-84, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18398511
16.
Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses.
J Virol
; 84(17): 8743-52, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20538860
17.
Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.
J Virol
; 84(19): 9907-19, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20668072
18.
Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory.
J Immunother Cancer
; 9(2)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579736
19.
A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS.
Vaccine
; 38(11): 2600-2607, 2020 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32057574
20.
Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial.
Vaccine
; 38(11): 2608-2619, 2020 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32057576